GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | -2.4% | 48,645 | 0.0% | 0.00% | – |
| Q2 2022 | $82,000 | -69.9% | 48,645 | -75.1% | 0.00% | – |
| Q1 2022 | $272,000 | -53.5% | 195,340 | -2.8% | 0.00% | – |
| Q4 2021 | $585,000 | -29.5% | 201,003 | -2.2% | 0.00% | – |
| Q3 2021 | $830,000 | -42.4% | 205,570 | -7.7% | 0.00% | – |
| Q2 2021 | $1,441,000 | +85.9% | 222,718 | +289.3% | 0.00% | – |
| Q1 2021 | $775,000 | – | 57,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $15,755,000 | 6.20% |
| Orbimed Advisors | 5,826,224 | $37,696,000 | 0.38% |
| Boxer Capital, LLC | 1,300,000 | $8,411,000 | 0.30% |
| Ikarian Capital, LLC | 426,455 | $2,759,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,135,000 | $13,813,000 | 0.21% |
| JS Capital Management LLC | 474,457 | $3,070,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,618,000 | 0.09% |
| Alyeska Investment Group, L.P. | 837,584 | $5,419,000 | 0.06% |
| Virtus ETF Advisers LLC | 19,673 | $127,000 | 0.05% |
| Caption Management, LLC | 384,900 | $2,488,000 | 0.03% |